AFFiRiS with its cutting-edge technology in the vaccine field can be an ideal partner to further underline the strengths of ProBioGen’s HuALN technology. We are very much looking towards this co-operation stated Michael Schlenk, CEO of ProBioGen. About AFFiRiS AG.. AACR, EmergingMed collaborate for connecting cancer patients with clinical trials in connection to SU2C broadcast The American Association for Cancer tumor Study announces its collaboration with the clinical trial navigation system EmergingMed, for connecting patients with clinical trials in link with the ENDURE Tumor broadcast which took place on Sept. 10, at 8 p.m. EDT & PDT / 7 p.m. CDT. The AACR-SU2C Clinical Trials Finder offers a resource for cancer patients and themselves to recognize clinical trials which may be appropriate for their particular diagnosis, stage and treatment history.No informed consent was required, as the data are anonymized. To acquire follow-up info, the CSRS and PCIRS were linked with the New York State Vital Statistics Death registry with the use of patient identifiers also to the Statewide Setting up and Research Cooperative Program registry with the use of patient identifiers, unique medical center identifiers, and dates of admission, surgery, and discharge. Details concerning the registries are included in the Supplementary Appendix, obtainable with the full text of this article at NEJM.org.